We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
Cap. Flow
+$1.37B
Cap. Flow %
18.68%
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$306M
2
CI icon
Cigna
CI
+$151M
3
PCRX icon
Pacira BioSciences
PCRX
+$143M
4
ENDP
Endo International plc
ENDP
+$120M
5
THC icon
Tenet Healthcare
THC
+$99.1M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$64.7M
2
BCR
CR Bard Inc.
BCR
+$62.4M
3
PRGO icon
Perrigo
PRGO
+$52.7M
4
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$49.4M
5
SKX
Skechers
SKX
+$47.1M

Sector Composition

Rank Sector Weight
1 Healthcare 50.8%
2 Financials 7.09%
3 Consumer Discretionary 5.97%
4 Energy 5.17%
5 Industrials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XL
26
DELISTED
XL Group Ltd.
XL
$44M 0.6%
1,210,885
+37,624
+3% +$1.42M
PRTA icon
27
Prothena Corp
PRTA
$440M
$43.5M 0.59%
959,427
-37,460
-4% -$2.18M
MHK icon
28
Mohawk Industries
MHK
$6.95B
$43M 0.59%
236,718
+184,422
+353% +$36.5M
ZLTQ
29
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$40.2M 0.55%
1,254,286
+860,998
+219% +$28.5M
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$39.7M 0.54%
990,379
-61,100
-6% -$1.99M
W icon
31
Wayfair
W
$11.8B
$39.6M 0.54%
1,129,667
+1,026,467
+995% +$39.4M
SAGE
32
DELISTED
Sage Therapeutics
SAGE
$38.2M 0.52%
902,948
+246,027
+37% +$15.2M
TSLA icon
33
PUT
Tesla
TSLA
$1.19T
$37.3M 0.51%
2,250,000
+2,227,500
+9,900% +$37.8M
CB icon
34
Chubb
CB
$141B
$37.1M 0.51%
358,580
+89,624
+33% +$9.37M
BKD icon
35
Brookdale Senior Living
BKD
$3.58B
$36.4M 0.5%
1,585,051
-893,927
-36% -$26.4M
MED icon
36
Medifast
MED
$108M
$36.3M 0.5%
1,350,000
– –
SLB icon
37
SLB Ltd
SLB
$73.3B
$36.1M 0.49%
522,924
+518,384
+11,418% +$41M
HZNP
38
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$35.5M 0.48%
1,789,014
+105,314
+6% +$3.33M
PPL
39
PPL Corp
PPL
$27.3B
$35.4M 0.48%
1,076,061
+219,245
+26% +$6.86M
PCP
40
DELISTED
PRECISION CASTPARTS CORP
PCP
$35M 0.48%
152,384
+150,694
+8,917% +$32.3M
GPK icon
41
Graphic Packaging
GPK
$3.31B
$34.9M 0.48%
2,724,985
+1,600,814
+142% +$22.8M
BHI
42
DELISTED
Baker Hughes
BHI
$34.1M 0.47%
655,024
+155,367
+31% +$8.68M
ALR
43
DELISTED
Alere Inc
ALR
$33.9M 0.46%
703,234
+188,420
+37% +$9.77M
EW icon
44
Edwards Lifesciences
EW
$48.9B
$33.5M 0.46%
1,412,652
-913,686
-39% -$22.1M
PFE icon
45
Pfizer
PFE
$144B
$31M 0.42%
1,041,018
+801,700
+335% +$25.7M
YHOO
46
DELISTED
Yahoo Inc
YHOO
$30.3M 0.41%
1,049,284
+177,726
+20% +$6.17M
KND
47
DELISTED
Kindred Healthcare
KND
$29.2M 0.4%
1,853,121
-92,719
-5% -$1.88M
CRM icon
48
Salesforce
CRM
$154B
$28.7M 0.39%
413,826
+66,797
+19% +$4.74M
VC icon
49
Visteon
VC
$2.83B
$28.6M 0.39%
282,433
+27,257
+11% +$2.74M
ACAD icon
50
Acadia Pharmaceuticals
ACAD
$4.49B
$28.5M 0.39%
861,420
+25,098
+3% +$1.04M
1
2
3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.

  • Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
  • Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
  • Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
  • Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
  • Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
  • Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
  • Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.